Literature DB >> 9526164

Screening 25 dystrophin gene exons for deletions in Arab children with Duchenne muscular dystrophy.

M Z Haider1, L Bastaki, Y Habib, A Moosa.   

Abstract

Forty-two Arab children with Duchenne muscular dystrophy (DMD) were studied for intragenic deletions in 25 exons of the dystrophin gene using three different multiplex PCR sets each amplifying a total of 9, 9 and 6 different exons, respectively. Exon 22 was amplified individually. Deletions were found in 78, 76 and 12% of DMD patients with each of the three sets, respectively. With all the three sets, the detection rate increased to 86% (36 of 42 patients). Fifty percent of the deleted exons were located in the distal hot spot, 8% in the proximal hot spot while 42% were scattered over both. This study, the first in an Arab population and only the second to use three PCR multiplex sets, documents one of the highest deletion detection rates in DMD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9526164     DOI: 10.1159/000022783

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  4 in total

1.  Deletional mutations of dystrophin gene and carrier detection in eastern India.

Authors:  Jayasri Basak; Uma B Dasgupta; Subhash Chandra Mukherjee; Shyamal Kumar Das; Asit Kumar Senapati; Tapas Kumar Banerjee
Journal:  Indian J Pediatr       Date:  2009-11-12       Impact factor: 1.967

2.  Patterns of dystrophin gene deletion in Egyptian Duchenne/Becker muscular dystrophy patients.

Authors:  R M El Sherif; N Aly Fahmy; I Nonaka; M A Etribi
Journal:  Acta Myol       Date:  2007-12

3.  Exon deletion pattern in duchene muscular dystrophy in north west of iran.

Authors:  Mohammad Barzegar; Parinaz Habibi; Mortaza Bonyady; Vahideh Topchizadeh; Shadi Shiva
Journal:  Iran J Child Neurol       Date:  2015

4.  DMD-related muscular dystrophy in Cameroon: Clinical and genetic profiles.

Authors:  Edmond Wonkam-Tingang; Séraphin Nguefack; Alina I Esterhuizen; David Chelo; Ambroise Wonkam
Journal:  Mol Genet Genomic Med       Date:  2020-06-15       Impact factor: 2.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.